INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13 | -100.0% | 23,700 | -35.2% | 0.00% | – |
| Q3 2022 | $43,000 | +95.5% | 36,595 | +91.6% | 0.00% | – |
| Q1 2022 | $22,000 | -85.7% | 19,100 | -71.0% | 0.00% | – |
| Q4 2021 | $154,000 | -54.2% | 65,800 | -39.0% | 0.00% | – |
| Q2 2021 | $336,000 | -11.1% | 107,942 | -13.7% | 0.00% | – |
| Q1 2021 | $378,000 | +822.0% | 125,147 | +572.8% | 0.00% | – |
| Q4 2020 | $41,000 | -32.8% | 18,600 | -63.6% | 0.00% | – |
| Q4 2018 | $61,000 | +3.4% | 51,029 | +136.2% | 0.00% | – |
| Q3 2018 | $59,000 | -28.0% | 21,600 | -44.9% | 0.00% | – |
| Q2 2018 | $82,000 | 0.0% | 39,210 | 0.0% | 0.00% | – |
| Q1 2018 | $82,000 | +26.2% | 39,210 | +22.9% | 0.00% | – |
| Q4 2017 | $65,000 | +62.5% | 31,900 | +30.2% | 0.00% | – |
| Q2 2017 | $40,000 | -71.4% | 24,500 | -41.7% | 0.00% | – |
| Q1 2017 | $140,000 | +211.1% | 42,039 | +26.7% | 0.00% | – |
| Q4 2016 | $45,000 | +9.8% | 33,184 | +23.3% | 0.00% | – |
| Q3 2016 | $41,000 | +95.2% | 26,903 | +76.3% | 0.00% | – |
| Q2 2016 | $21,000 | – | 15,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |